These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37726961)

  • 1. Effect of low-molecular-weight heparin on placenta-mediated fetal growth restriction in a tertiary referral hospital: A 7-year retrospective cohort study.
    Xu J; Tang Y; Peng B; Zhang WH; Wang X
    Int J Gynaecol Obstet; 2024 Apr; 165(1):220-228. PubMed ID: 37726961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental cord insertion distance from the placental margin and its association with adverse perinatal outcomes.
    Bigelow CA; Robles BN; Pan S; Overbey J; Robin E; Melamed A; Bianco A; Mella MT
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():51-55. PubMed ID: 33080485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
    Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Customized birth-weight centiles and placenta-related fetal growth restriction.
    Melamed N; Hiersch L; Aviram A; Keating S; Kingdom JC
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):409-416. PubMed ID: 33073889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.
    Heazell AE; Hayes DJ; Whitworth M; Takwoingi Y; Bayliss SE; Davenport C
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012245. PubMed ID: 31087568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of placenta previa on fetal growth restriction and stillbirth.
    Yeniel AO; Ergenoglu AM; Itil IM; Askar N; Meseri R
    Arch Gynecol Obstet; 2012 Aug; 286(2):295-8. PubMed ID: 22427011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial.
    Llurba E; Bella M; Burgos J; Mazarico E; Gómez-Roig MD; De Diego R; Martínez-Astorquiza T; Alijotas-Reig J; Sánchez-Durán MÁ; Sánchez O; Carreras E; Cabero L
    Fetal Diagn Ther; 2020; 47(11):824-833. PubMed ID: 33472201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Prospect Theory in Obstetrics by Evaluating Mode of Delivery and Outcomes in Neonates Born Small or Appropriate for Gestational Age.
    Michaeli J; Michaeli O; Rozitzky A; Grisaru-Granovsky S; Feldman N; Srebnik N
    JAMA Netw Open; 2022 Mar; 5(3):e222177. PubMed ID: 35289859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between antenatal diagnosis of late fetal growth restriction and educational outcomes in mid-childhood: A UK prospective cohort study with long-term data linkage study.
    Olga L; Sovio U; Wong H; Smith G; Aiken C
    PLoS Med; 2023 Apr; 20(4):e1004225. PubMed ID: 37093852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chemotherapy during pregnancy on fetal growth.
    Maggen C; Wolters VERA; Van Calsteren K; Cardonick E; Laenen A; Heimovaara JH; Mhallem Gziri M; Fruscio R; Duvekot JJ; Painter RC; Masturzo B; Shmakov RG; Halaska M; Berveiller P; Verheecke M; de Haan J; Gordijn SJ; Amant F;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10314-10323. PubMed ID: 36202393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of distinct features of villitis of unknown etiology histopathology and fetal growth restriction diagnosis in a retrospective cohort from Eastern Ontario.
    Osborne B; Oltean I; Sucha E; Mitsakakis N; Barrowman N; Bainbridge S; El Demellawy D
    Placenta; 2022 Oct; 128():83-90. PubMed ID: 36099701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcomes of very preterm infants born following early foetal growth restriction with absent end-diastolic umbilical flow.
    Della Gatta AN; Aceti A; Spinedi SF; Martini S; Corvaglia L; Sansavini A; Zuccarini M; Lenzi J; Seidenari A; Dionisi C; Pilu G; Simonazzi G
    Eur J Pediatr; 2023 Oct; 182(10):4467-4476. PubMed ID: 37490110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal detection of fetal growth restriction and risk of stillbirth: population-based case-control study.
    Ego A; Monier I; Skaare K; Zeitlin J
    Ultrasound Obstet Gynecol; 2020 May; 55(5):613-620. PubMed ID: 31364201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, clinical features and perinatal outcome in anomalous fetuses with late-onset growth restriction: cohort study.
    Dall'Asta A; Stampalija T; Mecacci F; Ramirez Zegarra R; Sorrentino S; Minopoli M; Ottaviani C; Fantasia I; Barbieri M; Lisi F; Simeone S; Castellani R; Fichera A; Rizzo G; Prefumo F; Frusca T; Ghi T
    Ultrasound Obstet Gynecol; 2022 Nov; 60(5):632-639. PubMed ID: 35638182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of maternal age on adverse pregnancy outcomes among primiparous women with singleton birth: a retrospective cohort study in urban areas of China.
    Li J; Yan J; Jiang W
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2250894. PubMed ID: 37635092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.
    Kennedy LM; Tong S; Robinson AJ; Hiscock RJ; Hui L; Dane KM; Middleton AL; Walker SP; MacDonald TM
    BMC Med; 2020 Dec; 18(1):395. PubMed ID: 33357243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Iatrogenic Delivery for Suspected Fetal Growth Restriction and Childhood School Outcomes.
    Selvaratnam RJ; Wallace EM; Wolfe R; Anderson PJ; Davey MA
    JAMA; 2021 Jul; 326(2):145-153. PubMed ID: 34255007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year experience of protocol-based management of small-for-gestational-age fetuses: perinatal outcome in late-pregnancy cases diagnosed after 32 weeks.
    Meler E; Mazarico E; Eixarch E; Gonzalez A; Peguero A; Martinez J; Boada D; Vellvé K; Gomez-Roig MD; Gratacós E; Figueras F
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):62-69. PubMed ID: 33159370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.